nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant chemotherapy—yes or no? Prognostic markers in early breast cancer
|
Piccart-Gebhart, M.J. |
|
|
|
S12 |
p. xii2-xii7 |
artikel |
2 |
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
|
Sánchez-Paulete, A.R. |
|
|
|
S12 |
p. xii74 |
artikel |
3 |
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
|
Sánchez-Paulete, A.R. |
|
|
|
S12 |
p. xii44-xii55 |
artikel |
4 |
Cancer immunotherapy full speed ahead
|
Melero, I. |
|
|
|
S12 |
p. xii1-xii2 |
artikel |
5 |
Editorial Board
|
|
|
|
|
S12 |
p. ii-iii |
artikel |
6 |
Informatics for cancer immunotherapy
|
Hammerbacher, J. |
|
|
|
S12 |
p. xii56-xii73 |
artikel |
7 |
Intratumoral immunotherapy: using the tumor as the remedy
|
Marabelle, A. |
|
|
|
S12 |
p. xii33-xii43 |
artikel |
8 |
introduction
|
Piccart-Gebhart, M.J. |
|
|
|
S12 |
p. xii1 |
artikel |
9 |
Markers predicting clinical benefit in breast cancer from microtubule-targeting agents
|
Pusztai, L. |
|
|
|
S12 |
p. xii15-xii20 |
artikel |
10 |
Mechanisms regulating T-cell infiltration and activity in solid tumors
|
Lanitis, E. |
|
|
|
S12 |
p. xii18-xii32 |
artikel |
11 |
New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer
|
Di Leo, A. |
|
|
|
S12 |
p. xii8-xii14 |
artikel |
12 |
Novel tools to assist neoepitope targeting in personalized cancer immunotherapy
|
Saini, S.K. |
|
|
|
S12 |
p. xii3-xii10 |
artikel |
13 |
Preclinical and clinical development of neoantigen vaccines
|
Li, L. |
|
|
|
S12 |
p. xii11-xii17 |
artikel |
14 |
Table of Contents
|
|
|
|
|
S12 |
p. v |
artikel |
15 |
Table of Contents
|
|
|
|
|
S12 |
p. iv |
artikel |
16 |
Title Page
|
|
|
|
|
S12 |
p. iv |
artikel |